News
Biotechnology
19 July 2024 Roche has announced two-year data from the Phase III Pagoda and Pavilion studies evaluating Susvimo
Today's issue
Refine Search
Pharmaceutical
Last week, US healthcare giant Johnson & Johnson kicked off the second-quarter financial reporting period, posting better than expected results and raising its full-year forecast. The USA’s Biomedical Advanced Research and Development Authority (BARDA) recently announced that it has committed up to $500 million to fund next generation COVID vaccines. US biotech Caribou Biosciences said it is refocusing its research and cutting back its workforce. Also of note, Roche subsidiary Genentech terminated its collaboration with US precision medicines company Relay Therapeutics on migoprotafib. 21 July 2024
Generics
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Friday approved the first generic raltegravir medicines to treat adult and pediatric HIV patients 20 July 2024
Pharmaceutical
Meitheal Pharmaceuticals has acquired North America rights to Contempo (fosfomycin for injection) from Nabriva Therapeutics. 20 July 2024
Biosimilars
Gedeon Richter today announced that the European Medicines Agency (EMA) has accepted the company’s two marketing authorization applications (MAAs) for its proposed biosimilar to denosumab. 19 July 2024
Biotechnology
Israel’s Teva Pharmaceutical Industries has presented positive topline results from its Phase III SPACE study of Ajovy (fremanezumab) for the prevention of episodic migraine in children and adolescent patients aged six to 17 years. 19 July 2024
Pharmaceutical
The National Institute for Health and Care Excellence’s (NICE), the cost-effectiveness watchdog for England and Wales, has published a Final Appraisal Document recommending the reimbursement of Orgovyx (relugolix) in prostate cancer. 19 July 2024
Pharmaceutical
French drugmaker Sanofi (Euronext: SAN) is reportedly planning a significant investment of over $400 million in its “global capacity center,” in Hyderabad, India. 19 July 2024
Pharmaceutical
Ardelyx has filed a lawsuit against the US Department of Health and Human Services DHSS) and the Centers for Medicare and Medicaid Services (CMS), regarding its Xpohzah. 19 July 2024
Biotechnology
Californian start-up Caribou Biosciences (Nasdaq: CRBU) has announced significant workforce reductions, cutting approximately 12% of its staff. 19 July 2024
Pharmaceutical
In New York, biotech firm Synaptogenix (Nasdaq: SNPX) has announced a new collaboration with LSU Health New Orleans. 19 July 2024
Pharmaceutical
Ono Pharmaceuticalannounced that the European Medicines Agency (EMA) has accepted the marketing authorization application (MAA) for vimseltinib. 19 July 2024
Biotechnology
Roche has announced two-year data from the Phase III Pagoda and Pavilion studies evaluating Susvimo 19 July 2024
Pharmaceutical
Boston, USA-based AVEO Oncology, a subsidiary of LG Chem (KRX: 051910), has announced that the TiNivo-2 Phase III trial did not meet its primary efficacy endpoint. 19 July 2024
Pharmaceutical
The US Food and Drug Administration (FDA) has approved Voquezna (vonoprazan) 10 mg tablets for the relief of heartburn associated with non-erosive gastroesophageal reflux disease (non-erosive GERD). 18 July 2024
Pharmaceutical
German family-owned pharma major Boehringer Ingelheim today reported significant progress in its pipeline across key therapeutic areas as it reached major milestones in the first half of the year. 18 July 2024
Pharmaceutical
An Expert View from William Hind of Alpharmaxim and Lisa Campbell of SSI Strategy. 18 July 2024
Biotechnology
Swedish firm Enzymatica (STO: ENZY) will conduct a rights issue to raise approximately $12 million, with existing shareholders being given preferential rights. 18 July 2024
Biosimilars
Privately-held German drugmaker Boehringer Ingelheim has inked a deal with GoodRx (Nasdaq: GDRX), in a bid to boost US penetration of its biosimilar to Humira (adalimumab). 18 July 2024
Pharmaceutical
60% of listed Indian pharmaceutical companies have experienced an uptick in new business inquiries from US pharma companies due to the discussions around the US Biosecure Act. 18 July 2024
Pharmaceutical
A new research paper concluding that the use of Inpefa (sotagliflozin) for the treatment of patients hospitalized for heart failure (HF) and suffering from co- morbid diabetes leads to significant positive impact on provider health system financial outcomes. 18 July 2024
All news
Pharmaceutical
Last week, US healthcare giant Johnson & Johnson kicked off the second-quarter financial reporting period, posting better than expected results and raising its full-year forecast. The USA’s Biomedical Advanced Research and Development Authority (BARDA) recently announced that it has committed up to $500 million to fund next generation COVID vaccines. US biotech Caribou Biosciences said it is refocusing its research and cutting back its workforce. Also of note, Roche subsidiary Genentech terminated its collaboration with US precision medicines company Relay Therapeutics on migoprotafib. 21 July 2024
Generics
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Friday approved the first generic raltegravir medicines to treat adult and pediatric HIV patients 20 July 2024
Pharmaceutical
Meitheal Pharmaceuticals has acquired North America rights to Contempo (fosfomycin for injection) from Nabriva Therapeutics. 20 July 2024
Biosimilars
Gedeon Richter today announced that the European Medicines Agency (EMA) has accepted the company’s two marketing authorization applications (MAAs) for its proposed biosimilar to denosumab. 19 July 2024
Biotechnology
Israel’s Teva Pharmaceutical Industries has presented positive topline results from its Phase III SPACE study of Ajovy (fremanezumab) for the prevention of episodic migraine in children and adolescent patients aged six to 17 years. 19 July 2024
Pharmaceutical
The National Institute for Health and Care Excellence’s (NICE), the cost-effectiveness watchdog for England and Wales, has published a Final Appraisal Document recommending the reimbursement of Orgovyx (relugolix) in prostate cancer. 19 July 2024
Pharmaceutical
French drugmaker Sanofi (Euronext: SAN) is reportedly planning a significant investment of over $400 million in its “global capacity center,” in Hyderabad, India. 19 July 2024
Pharmaceutical
Ardelyx has filed a lawsuit against the US Department of Health and Human Services DHSS) and the Centers for Medicare and Medicaid Services (CMS), regarding its Xpohzah. 19 July 2024
Biotechnology
Californian start-up Caribou Biosciences (Nasdaq: CRBU) has announced significant workforce reductions, cutting approximately 12% of its staff. 19 July 2024
Pharmaceutical
In New York, biotech firm Synaptogenix (Nasdaq: SNPX) has announced a new collaboration with LSU Health New Orleans. 19 July 2024
Pharmaceutical
Ono Pharmaceuticalannounced that the European Medicines Agency (EMA) has accepted the marketing authorization application (MAA) for vimseltinib. 19 July 2024
Biotechnology
Roche has announced two-year data from the Phase III Pagoda and Pavilion studies evaluating Susvimo 19 July 2024
Pharmaceutical
Boston, USA-based AVEO Oncology, a subsidiary of LG Chem (KRX: 051910), has announced that the TiNivo-2 Phase III trial did not meet its primary efficacy endpoint. 19 July 2024
Pharmaceutical
The US Food and Drug Administration (FDA) has approved Voquezna (vonoprazan) 10 mg tablets for the relief of heartburn associated with non-erosive gastroesophageal reflux disease (non-erosive GERD). 18 July 2024
Pharmaceutical
German family-owned pharma major Boehringer Ingelheim today reported significant progress in its pipeline across key therapeutic areas as it reached major milestones in the first half of the year. 18 July 2024
Pharmaceutical
An Expert View from William Hind of Alpharmaxim and Lisa Campbell of SSI Strategy. 18 July 2024
Biotechnology
Swedish firm Enzymatica (STO: ENZY) will conduct a rights issue to raise approximately $12 million, with existing shareholders being given preferential rights. 18 July 2024
Biosimilars
Privately-held German drugmaker Boehringer Ingelheim has inked a deal with GoodRx (Nasdaq: GDRX), in a bid to boost US penetration of its biosimilar to Humira (adalimumab). 18 July 2024
Pharmaceutical
60% of listed Indian pharmaceutical companies have experienced an uptick in new business inquiries from US pharma companies due to the discussions around the US Biosecure Act. 18 July 2024
Pharmaceutical
A new research paper concluding that the use of Inpefa (sotagliflozin) for the treatment of patients hospitalized for heart failure (HF) and suffering from co- morbid diabetes leads to significant positive impact on provider health system financial outcomes. 18 July 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze